Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach

M A de Graaf1, M L Antoni1, M M Ter Kuile2

  • 1Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333ZA Leiden, the Netherlands.

Eclinicalmedicine
|February 3, 2021
PubMed

Insights

Post-COVID-19 patients often experience functional limitations and cardiopulmonary issues, with Intensive Care Unit (ICU) survivors showing reduced lung function. Psychological distress was common across all patients.

Area of Science:

  • Cardiology
  • Pulmonology
  • Psychiatry

Background:

  • Short-term follow-up of COVID-19 patients reveals pulmonary dysfunction, myocardial damage, and psychological distress.
  • Limited data exists on the burden of these sequelae and follow-up recommendations.
  • This study evaluates cardiopulmonary function and psychological impairment post-hospitalization for COVID-19.

Purpose of the Study:

  • To assess the prevalence and nature of cardiopulmonary dysfunction and psychological impairment in patients after COVID-19 hospitalization.
  • To compare outcomes between patients admitted to the general ward versus the Intensive Care Unit (ICU).
  • To investigate the relationship between functional status and post-COVID-19 sequelae.

Main Methods:

  • Outpatient evaluation 6 weeks post-discharge.
  • Cardiopulmonary assessment using echocardiography, 24-hour ECG monitoring, and pulmonary function tests.
  • Psychological assessment via questionnaires and clinical interviews.

Main Results:

  • 62% of patients presented with New York Heart Association class II-III symptoms.
  • Left ventricular function was preserved in 78% of patients.
  • ICU patients exhibited significantly lower diffusion capacity and lung volumes (FEV1, FVC).
  • Rates of depression (17%), anxiety (5%), and PTSD (10%) were similar between ICU and non-ICU groups.

Conclusions:

  • Most COVID-19 survivors experience functional limitations, notably dyspnea on exertion, potentially linked to reduced diffusing capacity of the lungs for carbon monoxide (DLCOc).
  • Pulmonary fibrosis is a potential cause requiring long-term investigation.
  • Factors like mechanical ventilation, deconditioning, and pulmonary embolism may contribute to persistent issues.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
95
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
323
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
580
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
113
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
548